ºÝºÝߣshows by User: Jafaralimasi / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: Jafaralimasi / Mon, 19 Oct 2020 17:03:51 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: Jafaralimasi Gpat mcqs-series part 4 cns /slideshow/gpat-mcqsseries-part-4-cns/238915847 gpat-mcqs-seriespart4cns-201019170352
Neurohumoral transmission in the C.N.S with special emphasis on Pharmacology of various neurotransmitters. General anesthetics. Alcohols and disulfiram. Sedatives, hypnotics and centrally acting muscle relaxants, Psychopharmacological agents: Antipsychotics, antidepressants, antianxiety agents, anti-manics and hallucinogens. Anti-epileptic drugs. Anti-parkinsonism drugs. Nootropics. Narcotic analgesics, drug addiction, drug abuse, tolerance and dependence. GPAT-MCQS-SERIES PART-4 Central Nervous System GPAT/NIPER/DI EXAMS PREPARATION PHARMACY PHARMACOLOGY MEQS CNS MCQS ]]>
Neurohumoral transmission in the C.N.S with special emphasis on Pharmacology of various neurotransmitters. General anesthetics. Alcohols and disulfiram. Sedatives, hypnotics and centrally acting muscle relaxants, Psychopharmacological agents: Antipsychotics, antidepressants, antianxiety agents, anti-manics and hallucinogens. Anti-epileptic drugs. Anti-parkinsonism drugs. Nootropics. Narcotic analgesics, drug addiction, drug abuse, tolerance and dependence. GPAT-MCQS-SERIES PART-4 Central Nervous System GPAT/NIPER/DI EXAMS PREPARATION PHARMACY PHARMACOLOGY MEQS CNS MCQS ]]> Mon, 19 Oct 2020 17:03:51 GMT /slideshow/gpat-mcqsseries-part-4-cns/238915847 Jafaralimasi@slideshare.net(Jafaralimasi) Gpat mcqs-series part 4 cns Jafaralimasi Neurohumoral transmission in the C.N.S with special emphasis on Pharmacology of various neurotransmitters. General anesthetics. Alcohols and disulfiram. Sedatives, hypnotics and centrally acting muscle relaxants, Psychopharmacological agents: Antipsychotics, antidepressants, antianxiety agents, anti-manics and hallucinogens. Anti-epileptic drugs. Anti-parkinsonism drugs. Nootropics. Narcotic analgesics, drug addiction, drug abuse, tolerance and dependence. GPAT-MCQS-SERIES PART-4 Central Nervous System GPAT/NIPER/DI EXAMS PREPARATION PHARMACY PHARMACOLOGY MEQS CNS MCQS <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart4cns-201019170352-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Neurohumoral transmission in the C.N.S with special emphasis on Pharmacology of various neurotransmitters. General anesthetics. Alcohols and disulfiram. Sedatives, hypnotics and centrally acting muscle relaxants, Psychopharmacological agents: Antipsychotics, antidepressants, antianxiety agents, anti-manics and hallucinogens. Anti-epileptic drugs. Anti-parkinsonism drugs. Nootropics. Narcotic analgesics, drug addiction, drug abuse, tolerance and dependence. GPAT-MCQS-SERIES PART-4 Central Nervous System GPAT/NIPER/DI EXAMS PREPARATION PHARMACY PHARMACOLOGY MEQS CNS MCQS
Gpat mcqs-series part 4 cns from Jafarali Masi
]]> 1287 0 https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart4cns-201019170352-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Total quality management - QA - B.PHARMA /slideshow/total-quality-management-qa-bpharma/238915733 totalqualitymanagement-201019163845
Total Quality Management (TQM): Definition, elements, philosophies Bachelor of Pharmacy Subject Code: BP706TT SEMESTER: VII Subject Name: Quality Assurance JAFARALI MASI ]]>
Total Quality Management (TQM): Definition, elements, philosophies Bachelor of Pharmacy Subject Code: BP706TT SEMESTER: VII Subject Name: Quality Assurance JAFARALI MASI ]]> Mon, 19 Oct 2020 16:38:45 GMT /slideshow/total-quality-management-qa-bpharma/238915733 Jafaralimasi@slideshare.net(Jafaralimasi) Total quality management - QA - B.PHARMA Jafaralimasi Total Quality Management (TQM): Definition, elements, philosophies Bachelor of Pharmacy Subject Code: BP706TT SEMESTER: VII Subject Name: Quality Assurance JAFARALI MASI <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/totalqualitymanagement-201019163845-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Total Quality Management (TQM): Definition, elements, philosophies Bachelor of Pharmacy Subject Code: BP706TT SEMESTER: VII Subject Name: Quality Assurance JAFARALI MASI
Total quality management - QA - B.PHARMA from Jafarali Masi
]]> 525 0 https://cdn.slidesharecdn.com/ss_thumbnails/totalqualitymanagement-201019163845-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Gpat mcqs-series part 3 endocrine /slideshow/gpat-mcqsseries-part-3-endocrine/238905222 gpat-mcqs-seriespart3endocrine-201018082003
endocrine pharmacology. Hypothalamic and pituitary hormones. Thyroid hormones and ant thyroid drugs, Parathormone, Calcitonin and vitamin-D. Insulin, oral hypoglycemic agents and glucagon. ACTH and corticosteroids. Androgens and anabolic steroids. Estrogens, progesterone and oral contraceptives. Drugs acting on the uterus.]]>
endocrine pharmacology. Hypothalamic and pituitary hormones. Thyroid hormones and ant thyroid drugs, Parathormone, Calcitonin and vitamin-D. Insulin, oral hypoglycemic agents and glucagon. ACTH and corticosteroids. Androgens and anabolic steroids. Estrogens, progesterone and oral contraceptives. Drugs acting on the uterus.]]> Sun, 18 Oct 2020 08:20:03 GMT /slideshow/gpat-mcqsseries-part-3-endocrine/238905222 Jafaralimasi@slideshare.net(Jafaralimasi) Gpat mcqs-series part 3 endocrine Jafaralimasi endocrine pharmacology. Hypothalamic and pituitary hormones. Thyroid hormones and ant thyroid drugs, Parathormone, Calcitonin and vitamin-D. Insulin, oral hypoglycemic agents and glucagon. ACTH and corticosteroids. Androgens and anabolic steroids. Estrogens, progesterone and oral contraceptives. Drugs acting on the uterus. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart3endocrine-201018082003-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> endocrine pharmacology. Hypothalamic and pituitary hormones. Thyroid hormones and ant thyroid drugs, Parathormone, Calcitonin and vitamin-D. Insulin, oral hypoglycemic agents and glucagon. ACTH and corticosteroids. Androgens and anabolic steroids. Estrogens, progesterone and oral contraceptives. Drugs acting on the uterus.
Gpat mcqs-series part 3 endocrine from Jafarali Masi
]]> 1138 0 https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart3endocrine-201018082003-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Gpat mcqs-series part 2 ANS /slideshow/gpat-mcqsseries-part-2-ans/238905213 gpat-mcqs-seriespart2ans-201018081826
: Neurohumoral transmission (Autonomic and somatic). Parasympathomimetics, Parasympatholytics, Sympathomimetics, Sympatholytics, Ganglionic stimulants and blockers. Neuromuscular blocking agents and skeletal muscle relaxants (peripheral). Local anesthetic agents. Drugs used in Myasthenia Gravis. ]]>
: Neurohumoral transmission (Autonomic and somatic). Parasympathomimetics, Parasympatholytics, Sympathomimetics, Sympatholytics, Ganglionic stimulants and blockers. Neuromuscular blocking agents and skeletal muscle relaxants (peripheral). Local anesthetic agents. Drugs used in Myasthenia Gravis. ]]> Sun, 18 Oct 2020 08:18:26 GMT /slideshow/gpat-mcqsseries-part-2-ans/238905213 Jafaralimasi@slideshare.net(Jafaralimasi) Gpat mcqs-series part 2 ANS Jafaralimasi : Neurohumoral transmission (Autonomic and somatic). Parasympathomimetics, Parasympatholytics, Sympathomimetics, Sympatholytics, Ganglionic stimulants and blockers. Neuromuscular blocking agents and skeletal muscle relaxants (peripheral). Local anesthetic agents. Drugs used in Myasthenia Gravis. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart2ans-201018081826-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> : Neurohumoral transmission (Autonomic and somatic). Parasympathomimetics, Parasympatholytics, Sympathomimetics, Sympatholytics, Ganglionic stimulants and blockers. Neuromuscular blocking agents and skeletal muscle relaxants (peripheral). Local anesthetic agents. Drugs used in Myasthenia Gravis.
Gpat mcqs-series part 2 ANS from Jafarali Masi
]]> 1701 0 https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart2ans-201018081826-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Gpat mcqs-series part 1 basic pharmacology /slideshow/gpat-mcqsseries-part-1-basic-pharmacology/238905203 gpat-mcqs-seriespart1basicpharmacology-201018081538
Introduction to Pharmacology- Definition, scope and source of drugs, dosage form and routes of drug administration. Pharmacodynamics-Mechanism of drug action, Receptors, classification and drug receptors interaction, combined effect of drugs, factors modifying drug action. Pharmacokinetics-Mechanism and principle of Absorption, Distribution, Metabolism and Excretion of drugs. Principles of basic and clinical pharmacokinetics. Pharmacogenetics. Adverse drug reactions. Discovery and development of new drugs-Preclinical and clinical studies. mcqs gpat niper di]]>
Introduction to Pharmacology- Definition, scope and source of drugs, dosage form and routes of drug administration. Pharmacodynamics-Mechanism of drug action, Receptors, classification and drug receptors interaction, combined effect of drugs, factors modifying drug action. Pharmacokinetics-Mechanism and principle of Absorption, Distribution, Metabolism and Excretion of drugs. Principles of basic and clinical pharmacokinetics. Pharmacogenetics. Adverse drug reactions. Discovery and development of new drugs-Preclinical and clinical studies. mcqs gpat niper di]]> Sun, 18 Oct 2020 08:15:38 GMT /slideshow/gpat-mcqsseries-part-1-basic-pharmacology/238905203 Jafaralimasi@slideshare.net(Jafaralimasi) Gpat mcqs-series part 1 basic pharmacology Jafaralimasi Introduction to Pharmacology- Definition, scope and source of drugs, dosage form and routes of drug administration. Pharmacodynamics-Mechanism of drug action, Receptors, classification and drug receptors interaction, combined effect of drugs, factors modifying drug action. Pharmacokinetics-Mechanism and principle of Absorption, Distribution, Metabolism and Excretion of drugs. Principles of basic and clinical pharmacokinetics. Pharmacogenetics. Adverse drug reactions. Discovery and development of new drugs-Preclinical and clinical studies. mcqs gpat niper di <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart1basicpharmacology-201018081538-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Introduction to Pharmacology- Definition, scope and source of drugs, dosage form and routes of drug administration. Pharmacodynamics-Mechanism of drug action, Receptors, classification and drug receptors interaction, combined effect of drugs, factors modifying drug action. Pharmacokinetics-Mechanism and principle of Absorption, Distribution, Metabolism and Excretion of drugs. Principles of basic and clinical pharmacokinetics. Pharmacogenetics. Adverse drug reactions. Discovery and development of new drugs-Preclinical and clinical studies. mcqs gpat niper di
Gpat mcqs-series part 1 basic pharmacology from Jafarali Masi
]]> 1508 0 https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart1basicpharmacology-201018081538-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Ocular drug delivery system - NDDS - B.PHARMA /slideshow/ocular-drug-delivery-system-ndds-bpharma/238859004 oculardrugdeliverysystem-201013174148
Ocular drug delivery system - NDDS - B.PHARMA Introduction, intra ocular barriers and methods to overcome –Preliminary study, ocular formulations and ocuserts]]>
Ocular drug delivery system - NDDS - B.PHARMA Introduction, intra ocular barriers and methods to overcome –Preliminary study, ocular formulations and ocuserts]]> Tue, 13 Oct 2020 17:41:48 GMT /slideshow/ocular-drug-delivery-system-ndds-bpharma/238859004 Jafaralimasi@slideshare.net(Jafaralimasi) Ocular drug delivery system - NDDS - B.PHARMA Jafaralimasi Ocular drug delivery system - NDDS - B.PHARMA Introduction, intra ocular barriers and methods to overcome –Preliminary study, ocular formulations and ocuserts <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/oculardrugdeliverysystem-201013174148-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Ocular drug delivery system - NDDS - B.PHARMA Introduction, intra ocular barriers and methods to overcome –Preliminary study, ocular formulations and ocuserts
Ocular drug delivery system - NDDS - B.PHARMA from Jafarali Masi
]]> 3265 0 https://cdn.slidesharecdn.com/ss_thumbnails/oculardrugdeliverysystem-201013174148-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Intrauterine drug delivery system - ndds /slideshow/intrauterine-drug-delivery-system-ndds/238848517 intrauterinedrugdeliverysystem-201013050052
novel drug delivery system(NDDS) b.pharma semester 7, Intrauterine Drug Delivery Systems: Introduction, advantages and disadvantages, development of intra uterine devices (IUDs) and applications]]>
novel drug delivery system(NDDS) b.pharma semester 7, Intrauterine Drug Delivery Systems: Introduction, advantages and disadvantages, development of intra uterine devices (IUDs) and applications]]> Tue, 13 Oct 2020 05:00:51 GMT /slideshow/intrauterine-drug-delivery-system-ndds/238848517 Jafaralimasi@slideshare.net(Jafaralimasi) Intrauterine drug delivery system - ndds Jafaralimasi novel drug delivery system(NDDS) b.pharma semester 7, Intrauterine Drug Delivery Systems: Introduction, advantages and disadvantages, development of intra uterine devices (IUDs) and applications <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/intrauterinedrugdeliverysystem-201013050052-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> novel drug delivery system(NDDS) b.pharma semester 7, Intrauterine Drug Delivery Systems: Introduction, advantages and disadvantages, development of intra uterine devices (IUDs) and applications
Intrauterine drug delivery system - ndds from Jafarali Masi
]]> 4684 0 https://cdn.slidesharecdn.com/ss_thumbnails/intrauterinedrugdeliverysystem-201013050052-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Indian regulatory requirements - industrial pharmacy 2 /slideshow/indian-regulatory-requirements-industrial-pharmacy-2/238830101 indianregulatoryrequirements-201011114138
Indian Regulatory Requirements: Central Drug Standard Control Organization (CDSCO) and State Licensing Authority: Organization, Responsibilities, Certificate of Pharmaceutical Product (COPP), Regulatory requirements and approval procedures for New Drugs]]>
Indian Regulatory Requirements: Central Drug Standard Control Organization (CDSCO) and State Licensing Authority: Organization, Responsibilities, Certificate of Pharmaceutical Product (COPP), Regulatory requirements and approval procedures for New Drugs]]> Sun, 11 Oct 2020 11:41:38 GMT /slideshow/indian-regulatory-requirements-industrial-pharmacy-2/238830101 Jafaralimasi@slideshare.net(Jafaralimasi) Indian regulatory requirements - industrial pharmacy 2 Jafaralimasi Indian Regulatory Requirements: Central Drug Standard Control Organization (CDSCO) and State Licensing Authority: Organization, Responsibilities, Certificate of Pharmaceutical Product (COPP), Regulatory requirements and approval procedures for New Drugs <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/indianregulatoryrequirements-201011114138-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Indian Regulatory Requirements: Central Drug Standard Control Organization (CDSCO) and State Licensing Authority: Organization, Responsibilities, Certificate of Pharmaceutical Product (COPP), Regulatory requirements and approval procedures for New Drugs
Indian regulatory requirements - industrial pharmacy 2 from Jafarali Masi
]]> 7317 0 https://cdn.slidesharecdn.com/ss_thumbnails/indianregulatoryrequirements-201011114138-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Regulatory requirements for drug approval - industrial pharmacy II /slideshow/regulatory-requirements-for-drug-approval-industrial-pharmacy-ii/238799921 regulatoryrequirementsfordrugapproval-201008173754
Regulatory requirements for drug approval - industrial pharmacy IIDrug Development Teams, Non-Clinical Drug Development, Pharmacology, Drug Metabolism and Toxicology, General considerations of Investigational New Drug (IND) Application, Investigator’s Brochure (IB) and New Drug Application (NDA), Clinical research / BE studies, Clinical Research Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for FDA Submissions, Management of Clinical Studies.]]>
Regulatory requirements for drug approval - industrial pharmacy IIDrug Development Teams, Non-Clinical Drug Development, Pharmacology, Drug Metabolism and Toxicology, General considerations of Investigational New Drug (IND) Application, Investigator’s Brochure (IB) and New Drug Application (NDA), Clinical research / BE studies, Clinical Research Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for FDA Submissions, Management of Clinical Studies.]]> Thu, 08 Oct 2020 17:37:54 GMT /slideshow/regulatory-requirements-for-drug-approval-industrial-pharmacy-ii/238799921 Jafaralimasi@slideshare.net(Jafaralimasi) Regulatory requirements for drug approval - industrial pharmacy II Jafaralimasi Regulatory requirements for drug approval - industrial pharmacy IIDrug Development Teams, Non-Clinical Drug Development, Pharmacology, Drug Metabolism and Toxicology, General considerations of Investigational New Drug (IND) Application, Investigator’s Brochure (IB) and New Drug Application (NDA), Clinical research / BE studies, Clinical Research Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for FDA Submissions, Management of Clinical Studies. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/regulatoryrequirementsfordrugapproval-201008173754-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Regulatory requirements for drug approval - industrial pharmacy IIDrug Development Teams, Non-Clinical Drug Development, Pharmacology, Drug Metabolism and Toxicology, General considerations of Investigational New Drug (IND) Application, Investigator’s Brochure (IB) and New Drug Application (NDA), Clinical research / BE studies, Clinical Research Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for FDA Submissions, Management of Clinical Studies.
Regulatory requirements for drug approval - industrial pharmacy II from Jafarali Masi
]]> 10174 0 https://cdn.slidesharecdn.com/ss_thumbnails/regulatoryrequirementsfordrugapproval-201008173754-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pharmaceutical warehousing - quality assurance -B.PHARMA /slideshow/pharmaceutical-warehousing-quality-assurance-bpharma/238765694 pharmaceuticalwarehousing-201006181636
PHARMACEUTICAL WAREHOUSING QUALITY ASSURANCE BP706TT B.PHARMA SEMESTER 7 jsmasipharmacy.blogspot.com SYLLABUS Warehousing procedures,Premises,Storage Condition,Stock management,Documentation,Inventories,Reception of goods,Audit ]]>
PHARMACEUTICAL WAREHOUSING QUALITY ASSURANCE BP706TT B.PHARMA SEMESTER 7 jsmasipharmacy.blogspot.com SYLLABUS Warehousing procedures,Premises,Storage Condition,Stock management,Documentation,Inventories,Reception of goods,Audit ]]> Tue, 06 Oct 2020 18:16:36 GMT /slideshow/pharmaceutical-warehousing-quality-assurance-bpharma/238765694 Jafaralimasi@slideshare.net(Jafaralimasi) Pharmaceutical warehousing - quality assurance -B.PHARMA Jafaralimasi PHARMACEUTICAL WAREHOUSING QUALITY ASSURANCE BP706TT B.PHARMA SEMESTER 7 jsmasipharmacy.blogspot.com SYLLABUS Warehousing procedures,Premises,Storage Condition,Stock management,Documentation,Inventories,Reception of goods,Audit <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pharmaceuticalwarehousing-201006181636-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> PHARMACEUTICAL WAREHOUSING QUALITY ASSURANCE BP706TT B.PHARMA SEMESTER 7 jsmasipharmacy.blogspot.com SYLLABUS Warehousing procedures,Premises,Storage Condition,Stock management,Documentation,Inventories,Reception of goods,Audit
Pharmaceutical warehousing - quality assurance -B.PHARMA from Jafarali Masi
]]> 1191 0 https://cdn.slidesharecdn.com/ss_thumbnails/pharmaceuticalwarehousing-201006181636-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Quality management systems - INDUSTRIAL PHARMACY ll /slideshow/quality-management-systems-industrial-pharmacy-ll/238765657 qualitymanagementsystems-201006180310
syllabus Quality management & Certifications: Concept of Quality, Total Quality Management, Quality by Design (QbD), Six Sigma concept, Out of Specifications (OOS), Change control, Introduction to ISO 9000 series of quality systems standards, ISO 14000, NABL, GLP ]]>
syllabus Quality management & Certifications: Concept of Quality, Total Quality Management, Quality by Design (QbD), Six Sigma concept, Out of Specifications (OOS), Change control, Introduction to ISO 9000 series of quality systems standards, ISO 14000, NABL, GLP ]]> Tue, 06 Oct 2020 18:03:10 GMT /slideshow/quality-management-systems-industrial-pharmacy-ll/238765657 Jafaralimasi@slideshare.net(Jafaralimasi) Quality management systems - INDUSTRIAL PHARMACY ll Jafaralimasi syllabus Quality management & Certifications: Concept of Quality, Total Quality Management, Quality by Design (QbD), Six Sigma concept, Out of Specifications (OOS), Change control, Introduction to ISO 9000 series of quality systems standards, ISO 14000, NABL, GLP <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/qualitymanagementsystems-201006180310-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> syllabus Quality management &amp; Certifications: Concept of Quality, Total Quality Management, Quality by Design (QbD), Six Sigma concept, Out of Specifications (OOS), Change control, Introduction to ISO 9000 series of quality systems standards, ISO 14000, NABL, GLP
Quality management systems - INDUSTRIAL PHARMACY ll from Jafarali Masi
]]> 17450 0 https://cdn.slidesharecdn.com/ss_thumbnails/qualitymanagementsystems-201006180310-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Regulatory affairs - industrial pharmacy II /slideshow/regulatory-affairs-industrial-pharmacy-ii/238732065 regulatoryaffairs-201004165617
click here jsmasipharmacy.blogspot.com https://jsmasipharmacy.blogspot.com/2020/10/regulatory-affairs-industrial-pharmacy.html]]>
click here jsmasipharmacy.blogspot.com https://jsmasipharmacy.blogspot.com/2020/10/regulatory-affairs-industrial-pharmacy.html]]> Sun, 04 Oct 2020 16:56:17 GMT /slideshow/regulatory-affairs-industrial-pharmacy-ii/238732065 Jafaralimasi@slideshare.net(Jafaralimasi) Regulatory affairs - industrial pharmacy II Jafaralimasi click here jsmasipharmacy.blogspot.com https://jsmasipharmacy.blogspot.com/2020/10/regulatory-affairs-industrial-pharmacy.html <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/regulatoryaffairs-201004165617-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> click here jsmasipharmacy.blogspot.com https://jsmasipharmacy.blogspot.com/2020/10/regulatory-affairs-industrial-pharmacy.html
Regulatory affairs - industrial pharmacy II from Jafarali Masi
]]> 6336 0 https://cdn.slidesharecdn.com/ss_thumbnails/regulatoryaffairs-201004165617-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Technology development and transfer industrial pharmacy ll /slideshow/technology-development-and-transfer-industrial-pharmacy-ll/238732053 technologydevelopmentandtransferindustrialpharmacyll-201004165059
visit website https://jsmasipharmacy.blogspot.com/2020/10/technology-development-and-transfer.html jsmasipharmacy.blogspot.com]]>
visit website https://jsmasipharmacy.blogspot.com/2020/10/technology-development-and-transfer.html jsmasipharmacy.blogspot.com]]> Sun, 04 Oct 2020 16:50:59 GMT /slideshow/technology-development-and-transfer-industrial-pharmacy-ll/238732053 Jafaralimasi@slideshare.net(Jafaralimasi) Technology development and transfer industrial pharmacy ll Jafaralimasi visit website https://jsmasipharmacy.blogspot.com/2020/10/technology-development-and-transfer.html jsmasipharmacy.blogspot.com <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/technologydevelopmentandtransferindustrialpharmacyll-201004165059-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> visit website https://jsmasipharmacy.blogspot.com/2020/10/technology-development-and-transfer.html jsmasipharmacy.blogspot.com
Technology development and transfer industrial pharmacy ll from Jafarali Masi
]]> 15351 0 https://cdn.slidesharecdn.com/ss_thumbnails/technologydevelopmentandtransferindustrialpharmacyll-201004165059-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Pilot plant scale up techniques - industrial pharmacy II /slideshow/pilot-plant-scale-up-techniques-industrial-pharmacy-ii/238732030 pilotplantscaleuptechniques-201004164113
visit website for more https://jsmasipharmacy.blogspot.com/2020/10/pilot-plant-scale-up-techniques-bp702tt.html jsmasipharmacy.blogspot.com]]>
visit website for more https://jsmasipharmacy.blogspot.com/2020/10/pilot-plant-scale-up-techniques-bp702tt.html jsmasipharmacy.blogspot.com]]> Sun, 04 Oct 2020 16:41:13 GMT /slideshow/pilot-plant-scale-up-techniques-industrial-pharmacy-ii/238732030 Jafaralimasi@slideshare.net(Jafaralimasi) Pilot plant scale up techniques - industrial pharmacy II Jafaralimasi visit website for more https://jsmasipharmacy.blogspot.com/2020/10/pilot-plant-scale-up-techniques-bp702tt.html jsmasipharmacy.blogspot.com <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/pilotplantscaleuptechniques-201004164113-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> visit website for more https://jsmasipharmacy.blogspot.com/2020/10/pilot-plant-scale-up-techniques-bp702tt.html jsmasipharmacy.blogspot.com
Pilot plant scale up techniques - industrial pharmacy II from Jafarali Masi
]]> 8594 0 https://cdn.slidesharecdn.com/ss_thumbnails/pilotplantscaleuptechniques-201004164113-thumbnail.jpg?width=120&height=120&fit=bounds document Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://public.slidesharecdn.com/v2/images/profile-picture.png https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart4cns-201019170352-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/gpat-mcqsseries-part-4-cns/238915847 Gpat mcqs-series part ... https://cdn.slidesharecdn.com/ss_thumbnails/totalqualitymanagement-201019163845-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/total-quality-management-qa-bpharma/238915733 Total quality manageme... https://cdn.slidesharecdn.com/ss_thumbnails/gpat-mcqs-seriespart3endocrine-201018082003-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/gpat-mcqsseries-part-3-endocrine/238905222 Gpat mcqs-series part ...